Page last updated: 2024-10-29

imipramine and De Lange Syndrome

imipramine has been researched along with De Lange Syndrome in 1 studies

Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.

De Lange Syndrome: A syndrome characterized by growth retardation, severe MENTAL RETARDATION, short stature, a low-pitched growling cry, brachycephaly, low-set ears, webbed neck, carp mouth, depressed nasal bridge, bushy eyebrows meeting at the midline, hirsutism, and malformations of the hands. The condition may occur sporadically or be associated with an autosomal dominant pattern of inheritance or duplication of the long arm of chromosome 3. (Menkes, Textbook of Child Neurology, 5th ed, p231)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
O'Neil, M1
Page, N1
Adkins, WN1
Eichelman, B1

Other Studies

1 other study available for imipramine and De Lange Syndrome

ArticleYear
Tryptophan-trazodone treatment of aggressive behaviour.
    Lancet (London, England), 1986, Oct-11, Volume: 2, Issue:8511

    Topics: Adult; Aggression; De Lange Syndrome; Drug Therapy, Combination; Humans; Imipramine; Male; Trazodone

1986